L’Oreal Creams Vetted by FDA in Drugs-as-Cosmetics Crackdown

L’Oreal SA, the world’s largest cosmetics maker, is being told by U.S. regulators to tone down claims on its Lancome anti-aging creams or submit the products to a drug review process reserved for pharmaceutical companies.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.